Aripiprazole Linked to Lower Hyponatremia Risk Than Olanzapine, Large Study Finds
A two-stage analysis combining FDA adverse event reports with Japanese claims data found aripiprazole associated with a significantly lower risk ...
Tag: second-generation antipsychotics
Second-Gen Antipsychotics Impact Metabolic Health in Schizophrenia
In a groundbreaking new study set to reshape clinical approaches to schizophrenia treatment, researchers have unveiled critical insights into the ...
Cardiovascular Risks of Antipsychotics in Severe Illness
In a groundbreaking study published in Nature Communications in 2025, researchers have unveiled critical insights into the cardiovascular safety profiles ...
Aripiprazole vs. Risperidone: Metabolic Effects Compared
In the continuously evolving landscape of schizophrenia treatment, addressing the metabolic side effects of antipsychotic medications remains a crucial challenge ...
Boosting Depression Treatment: Second-Gen Antipsychotics’ Impact
In an era where treatment-resistant depression (TRD) remains a formidable challenge in psychiatric medicine, a groundbreaking network meta-regression analysis has ...
-
Mothers who receive childcare support from maternal grandparents show more parental warmth, finds NTU Singapore study
-
University of Seville Breaks 120-Year-Old Mystery, Revises a Key Einstein Concept
-
Bee body mass, pathogens and local climate influence heat tolerance
-
Researchers record first-ever images and data of a shark experiencing a boat strike
-
Groundbreaking Clinical Trial Reveals Lubiprostone Enhances Kidney Function
Embark on a thrilling journey of discovery with Scienmag.com—your ultimate source for cutting-edge breakthroughs. Immerse yourself in a world where curiosity knows no limits and tomorrow’s possibilities become today’s reality!